Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium Acid Phosphate OTF vs Oral Solution in Preterm Neonates
NCT01676844Phase 2Unknown
- Sponsor
- University of Strathclyde
- Start
- Feb 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of potassium dihydrogen phosphate in hypophosphatemia, osteopenia of prematurity (MBD), sponsored by University of Strathclyde. Status: unknown.
02
Drugs
potassium dihydrogen phosphate
03
Conditions
hypophosphatemiaosteopenia of prematurity (MBD)
Beyond the preview
Go deeper on NCT01676844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676844.